The Congress meeting is acknowledged as the key event where clinical and scientific progress in PD and HHD is presented. This is where leading edge research is presented by today’s and tomorrow’s committed clinicians and scientists in this specialised field. It will offer valuable networking opportunities and is expected to attract around 500-600 delegates from around the world – previous meetings have had over 50 countries represented. The exhibition will be the hub of the congress, providing a space for people to connect with industry friends and colleagues.

Sponsoring the 2023 meeting will provide:

• Outstanding access to the key international experts in the clinical management and scientific research of PD and HHD
• Extensive global marketing visibility with ongoing visibility on the Congress website and a direct link to your website
• Opportunities to identify cutting edge topical issues: clinical, pre-clinical, and research and development
• Establishment of relationships with the current and future leaders in the field.

The EuroPD meetings are made possible because of our longstanding partnerships with sponsors, exhibitors and collaborators. We are very appreciative of this ongoing support and collaboration, and look forward to you joining us in Bruges.